• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期新冠综合征表现为自闭症谱系障碍中的神经精神症状加重:治疗见解

Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment.

作者信息

Jyonouchi Harumi, Geng Lee, Rossignol Daniel A, Frye Richard E

机构信息

Saint Peter's University Hospital (SPUH), New Brunswick, NJ 08901, USA.

Rossignol Medical Center, Aliso Viejo, CA 92656, USA.

出版信息

J Pers Med. 2022 Nov 2;12(11):1815. doi: 10.3390/jpm12111815.

DOI:10.3390/jpm12111815
PMID:36579544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9695881/
Abstract

COVID-19 causes not only severe respiratory symptoms, but also long-term sequelae, even if the acute-phase symptoms are minor. Neurological and neuropsychiatric symptoms are emerging as major long-term sequalae. In patients with pre-existing behavioral symptoms, such as individuals with autism spectrum disorders (ASD), the emergence of neuropsychiatric symptoms due to long COVID can be difficult to diagnose and manage. Herein, we present three ASD cases who presented with markedly worsening neuropsychiatric symptoms following COVID-19 exposure and subsequent difficulty in managing the post-COVID neuropsychiatric symptoms. Case 1 contracted SARS-CoV-2 during the early stages of the pandemic and treatment targeting COVID-19-induced immune activation was delayed. Case 2 was asymptomatic in the acute stage of a confirmed COVID-19 exposure, but still developed significant neuropsychiatric symptoms. Case 3 demonstrated a difficult course, partly due to pre-existing immune dysregulation and prior use of multiple immunomodulating agents. In cases 1 and 3 for whom serial blood samples were obtained, notable changes in the production of inflammatory and counter-regulatory cytokines by peripheral blood monocytes were observed. The presented cases illustrate the profound effects of COVID-19 on neuropsychiatric symptoms in ASD subjects and the difficulty of managing long-COVID symptoms.

摘要

新冠病毒病不仅会引发严重的呼吸道症状,还会导致长期后遗症,即便急性期症状轻微。神经和神经精神症状正成为主要的长期后遗症。在患有如自闭症谱系障碍(ASD)等既往行为症状的患者中,长期新冠导致的神经精神症状可能难以诊断和处理。在此,我们报告三例ASD病例,这些病例在接触新冠病毒后神经精神症状明显恶化,随后在处理新冠后神经精神症状时遇到困难。病例1在疫情早期感染了严重急性呼吸综合征冠状病毒2(SARS-CoV-2),针对新冠病毒诱导的免疫激活的治疗被推迟。病例2在确诊接触新冠病毒的急性期无症状,但仍出现了明显的神经精神症状。病例3病程艰难,部分原因是既往存在免疫失调以及先前使用过多种免疫调节药物。在获取了系列血样的病例1和病例3中,观察到外周血单核细胞产生的炎性和反调节细胞因子有显著变化。所报告的病例说明了新冠病毒病对ASD患者神经精神症状的深远影响以及处理长期新冠症状的困难。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99af/9695881/2b0a2b3d0a5d/jpm-12-01815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99af/9695881/2b0a2b3d0a5d/jpm-12-01815-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99af/9695881/2b0a2b3d0a5d/jpm-12-01815-g001.jpg

相似文献

1
Long COVID Syndrome Presenting as Neuropsychiatric Exacerbations in Autism Spectrum Disorder: Insights for Treatment.长期新冠综合征表现为自闭症谱系障碍中的神经精神症状加重:治疗见解
J Pers Med. 2022 Nov 2;12(11):1815. doi: 10.3390/jpm12111815.
2
Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?外周血单核细胞的细胞因子谱与一部分自闭症谱系障碍(ASD)受试者免疫损伤后行为症状的变化相关:一种炎症亚型?
J Neuroinflammation. 2014 Oct 27;11:187. doi: 10.1186/s12974-014-0187-2.
3
Severe and long-lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID-19: A case report.新冠感染后出现轻微呼吸道症状但伴有严重且持久的神经精神症状:病例报告。
Neuropsychopharmacol Rep. 2022 Mar;42(1):114-119. doi: 10.1002/npr2.12222. Epub 2021 Dec 10.
4
New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).新发神经精神后遗症与“长新冠”综合征(综述)
Exp Ther Med. 2022 Oct 4;24(5):705. doi: 10.3892/etm.2022.11641. eCollection 2022 Nov.
5
Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study.自闭症谱系障碍(ASD)和特定多糖抗体缺陷(SPAD)患儿外周血(PB)单核细胞的免疫特征和转录谱分析:病例研究。
J Neuroinflammation. 2012 Jan 7;9:4. doi: 10.1186/1742-2094-9-4.
6
MicroRNA expression changes in association with changes in interleukin-1ß/interleukin10 ratios produced by monocytes in autism spectrum disorders: their association with neuropsychiatric symptoms and comorbid conditions (observational study).自闭症谱系障碍患者单核细胞产生的白细胞介素-1β/白细胞介素 10 比值变化相关的 microRNA 表达变化:与神经精神症状和共病的关系(观察性研究)。
J Neuroinflammation. 2017 Nov 25;14(1):229. doi: 10.1186/s12974-017-1003-6.
7
Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis.重症 COVID-19 患者的长期神经后遗症:系统评价与荟萃分析
Cureus. 2022 Sep 28;14(9):e29694. doi: 10.7759/cureus.29694. eCollection 2022 Sep.
8
Ischemic Vasculitis as a Cause of Brain Disorder's in Patients with Long Covid: Case Report.长新冠患者脑功能障碍的病因:缺血性血管炎:病例报告。
Med Arch. 2021 Dec;75(6):471-474. doi: 10.5455/medarh.2021.75.471-474.
9
Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study.与新型冠状病毒肺炎相关的神经精神症状及其潜在的神经系统感染机制:影像学在该研究中的作用
Psychoradiology. 2021 Dec 22;1(4):199-211. doi: 10.1093/psyrad/kkab019. eCollection 2021 Dec.
10
Neuropsychiatric Disorders in Pediatric Long COVID-19: A Case Series.儿童新冠长期症状中的神经精神障碍:病例系列
Brain Sci. 2022 Apr 19;12(5):514. doi: 10.3390/brainsci12050514.

引用本文的文献

1
Favorable responses to upadacitinib, a JAK1 inhibitor, in long COVID patients with predominant neuropsychiatric symptoms: case reports in 2 autistic patients and one typically developing patient.JAK1抑制剂乌帕替尼对以神经精神症状为主的长期新冠患者有良好反应:2例自闭症患者和1例发育正常患者的病例报告
BMC Neurol. 2025 Aug 20;25(1):342. doi: 10.1186/s12883-025-04341-y.
2
Long COVID in people with mental health disorders: a scoping review.精神健康障碍患者的长期新冠症状:一项范围综述
BMC Psychiatry. 2025 Jul 1;25(1):669. doi: 10.1186/s12888-025-06935-9.
3
Neuropsychiatric Burden of SARS-CoV-2: A Review of Its Physiopathology, Underlying Mechanisms, and Management Strategies.

本文引用的文献

1
Parents' personality, parenting stress, and problem behaviors of children with special needs in China before and during the COVID-19 pandemic.新冠疫情之前及期间中国特殊需求儿童家长的性格、育儿压力及问题行为
Curr Psychol. 2022 Oct 19:1-12. doi: 10.1007/s12144-022-03869-3.
2
Changes in Mental Health during Three Waves of the COVID-19 Pandemic in Slovakia: Neurotypical Children versus Children with Autism Spectrum Disorder and Their Parents.新冠疫情在斯洛伐克的三次浪潮期间对精神健康的影响:神经典型儿童与自闭症谱系障碍儿童及其父母。
Int J Environ Res Public Health. 2022 Sep 20;19(19):11849. doi: 10.3390/ijerph191911849.
3
新型冠状病毒 2 型的神经精神负担:对其病理生理学、潜在机制及管理策略的综述
Viruses. 2024 Nov 21;16(12):1811. doi: 10.3390/v16121811.
4
Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic.自闭症谱系障碍与抗炎治疗的潜在作用:儿科过敏/免疫诊所的经验
Front Psychiatry. 2024 Jun 24;15:1333717. doi: 10.3389/fpsyt.2024.1333717. eCollection 2024.
5
Synchrony 2022: Catalyzing Research and Treatments to Benefit Individuals with Neurodevelopmental Disorders including Autism Spectrum Disorders.同步2022:推动研究与治疗,造福包括自闭症谱系障碍在内的神经发育障碍患者。
J Pers Med. 2023 Mar 9;13(3):490. doi: 10.3390/jpm13030490.
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
轻度呼吸道感染 COVID 可导致多谱系神经细胞和髓鞘失调。
Cell. 2022 Jul 7;185(14):2452-2468.e16. doi: 10.1016/j.cell.2022.06.008. Epub 2022 Jun 13.
4
Epigenetics and Neuroinflammation Associated With Neurodevelopmental Disorders: A Microglial Perspective.与神经发育障碍相关的表观遗传学和神经炎症:小胶质细胞视角
Front Cell Dev Biol. 2022 May 12;10:852752. doi: 10.3389/fcell.2022.852752. eCollection 2022.
5
Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics.瑞德西韦及其与再利用药物的联合应用作为 COVID-19 治疗药物。
Front Immunol. 2022 May 12;13:830990. doi: 10.3389/fimmu.2022.830990. eCollection 2022.
6
The mental health and well-being of adults with intellectual disability during the COVID-19 pandemic: A narrative review.新冠疫情期间成年智力残疾者的心理健康与福祉:一项叙述性综述
J Policy Pract Intellect Disabil. 2022 Mar;19(1):35-47. doi: 10.1111/jppi.12412. Epub 2022 Feb 25.
7
Efficacy of Colchicine in the Treatment of COVID-19 Patients: A Systematic Review and Meta-Analysis.秋水仙碱治疗新冠病毒肺炎患者的疗效:一项系统评价与荟萃分析
J Clin Med. 2022 May 6;11(9):2615. doi: 10.3390/jcm11092615.
8
Inflammasome activation in infected macrophages drives COVID-19 pathology.在被感染的巨噬细胞中激活炎症小体导致 COVID-19 病理学。
Nature. 2022 Jun;606(7914):585-593. doi: 10.1038/s41586-022-04802-1. Epub 2022 Apr 28.
9
Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19.激酶抑制剂作为治疗新冠病毒病的潜在治疗药物
Front Pharmacol. 2022 Apr 4;13:806568. doi: 10.3389/fphar.2022.806568. eCollection 2022.
10
COVID-19 and children: medical impact and collateral damage.新冠病毒与儿童:医疗影响与附带损害。
Microb Biotechnol. 2022 Apr;15(4):1035-1049. doi: 10.1111/1751-7915.14018. Epub 2022 Feb 19.